Filing Details
- Accession Number:
- 0001062993-18-003575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-29 16:20:35
- Reporting Period:
- 2018-08-27
- Accepted Time:
- 2018-08-29 16:20:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375378 | Paul Gitman | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2018-08-27 | 10,000 | $50.11 | 30,000 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2018-08-28 | 5,000 | $48.88 | 25,000 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2018-08-29 | 5,000 | $49.79 | 20,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The selling price of $50.1144 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.23 to $52.19. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $48.8831 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.68 to $49.41. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $49.7946 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.35 to $50.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
